New-onset thyroid eye disease after COVID-19 vaccination in a radioactive iodine-treated graves’ disease patient: A case report and literature review
- Author:
Jamie Hong Im Teoh
1
;
Norlaila Mustafa
1
;
Norasyikin Wahab
1
Author Information
- Publication Type:Case Reports
- Keywords: Radioactive iodine therapy; autoimmune/inflammatory syndrome induced by adjuvants
- MeSH: Thyroid eye disease; SARS-CoV-2 vaccine; Molecular Mimicry
- From: Journal of the ASEAN Federation of Endocrine Societies 2023;38(1):125-130
- CountryPhilippines
- Language:English
- Abstract: Autoimmunity associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been well-described as the mechanism of development of thyroid dysfunction following Coronavirus Disease 19 (COVID-19) infection and SARS-CoV-2 vaccination. However, the occurrence of thyroid eye disease (TED) after SARS-CoV-2 vaccination is scarcely described. The postulated mechanisms include immune reactivation, molecular mimicry and the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). We report a case of new-onset TED after receiving the SARSCoV- 2 vaccine.
- Full text:2543-Article Text-23125-1-10-20230517.pdf
